An advertisement for Nucynta ER consisting of 3 data visualizations. A table discusses the "Tolerability profile" of Nucynta ER in comparison to a placebo and Oxycodone CR. A poll discusses the discontinuation rate of Nucynta ER in comparison to a placebo and Oxycodone CR. A bar graph discusses the "GI tolerability" of Nucynta ER in comparison to a placebo and Oxycodone CR. The collective argument is that Nucynta ER is a superior product to Oxycodone CR as it causes fewer adverse events is less likely to be discontinued and is less likely to induce nausea and/or vomiting. The background is white with design elements in red yellow and green and text in black.

• Graph or Chart

• Sales and Marketing